Exhibit 31.1

     Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Jonathan Doctor, Chief Executive Officer and President of PracticeXpert, Inc.
(the "registrant"), certify that:

1.       I have reviewed this quarterly report on Form 10-QSB of the registrant;
         for the quarterly period ended September 30, 2005;

2.       Based on my  knowledge,  this  quarterly  report  does not  contain any
         untrue  statement of a material  fact or omit to state a material  fact
         necessary to make the  statements  made, in light of the  circumstances
         under which such  statements  were made, not misleading with respect to
         the period covered by this quarterly report;

3.       Based on my knowledge,  the financial  statements,  and other financial
         information  included in this quarterly  report,  fairly present in all
         material  respects the financial  condition,  results of operations and
         cash flows of the  registrant as of, and for, the periods  presented in
         this quarterly report;

4.       I am responsible for establishing and maintaining  disclosure  controls
         and  procedures  (as  defined  in  Exchange  Act  Rules  13a-15(e)  and
         15d-15(e)) and internal control over financial reporting (as defined in
         Exchange Act Rules  13a-15(f) and  15d-15(f))  for the  registrant  and
         have:

a.       designed  such  disclosure  controls  and  procedures,  or caused  such
         disclosure   controls  and   procedures   to  be  designed   under  our
         supervision,  to  ensure  that  material  information  relating  to the
         registrant,  including its consolidated subsidiaries,  is made known to
         us by others within those entities,  particularly  during the period in
         which this quarterly report is prepared;

b.       designed such internal control over financial reporting, or caused such
         internal  control over  financial  reporting  to be designed  under our
         supervision,  to provide reasonable assurance regarding the reliability
         of financial reporting and the preparation of financial  statements for
         external  purposes in accordance  with  generally  accepted  accounting
         principles;

c.       evaluated the effectiveness of the registrant's disclosure controls and
         procedures and presented in this quarterly report our conclusions about
         the  effectiveness of the disclosure  controls and procedures as of the
         end of the  period  covered  by this  quarterly  report  based  on such
         evaluation; and

d.       disclosed  in this  quarterly  report  any  change in the  registrant's
         internal  control over  financial  reporting  that occurred  during the
         registrant's  most recent fiscal quarter that has materially  affected,
         or is reasonably likely to materially affect, the registrant's internal
         control over financial reporting; and

5.       I have  disclosed,  based  on my most  recent  evaluation  of  internal
         control over financial reporting,  to the registrant's auditors and the
         audit  committee  of  registrant's   board  of  directors  (or  persons
         performing the equivalent functions):

              a) all  significant  deficiencies  and material  weaknesses in the
         design or operation of internal control over financial  reporting which
         are reasonably  likely to adversely affect the registrant's  ability to
         record, process, summarize and report financial information; and

              b) any fraud, whether or not material, that involves management or
         other  employees  who  have a  significant  role  in  the  registrant's
         internal control over financial reporting.

                                 Date:  November 25, 2005

                                 By:  /s/ Jonathan Doctor
                                    --------------------------------------------
                                       Jonathan Doctor,
                                       Chief Executive Officer and President